Status:
COMPLETED
Use and Harm Exposure in New Low Nicotine Cigarettes
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Cigarette Smoking
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The proposed research extends previous research on Quest® cigarette smoking behavior by testing whether compensatory smoking occurs as cigarette nicotine level decreases, and whether, as a result, bio...
Eligibility Criteria
Inclusion
- Self-report smoking \> 15 daily cigarettes.
- Self-report smoking only non-menthol cigarettes.
- Not currently trying to quit smoking, or planning to quit in the next 2 months.
- Interested in trying a new cigarette-like product.
Exclusion
- Not meeting any of the inclusion criteria.
- Self-report drinking \> 25 alcohol-containing drinks per week.
- Self-report currently using any nicotine replacement products.
- Self-report substance use disorders (abuse or dependence involving alcohol, cocaine, or stimulants, benzodiazepines, not nicotine) in the last 5 years.
- Self-report past history of Axis I psychiatric disorders other than depression
- Self-report myocardial infarct within the past year.
- Females must not be currently pregnant, planning a pregnancy during the study, or currently breastfeeding/lactating.
- Provide a baseline CO reading \< 10 ppm
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT01202942
Start Date
July 1 2007
End Date
June 1 2013
Last Update
December 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tobacco Use Research Center, UPenn
Philadelphia, Pennsylvania, United States, 19104